Press Releases

E-mail Alerts

You may automatically receive Verastem Oncology financial information by e-mail. To choose your options for e-mail notification, please enter your e-mail address below and click Submit.

Required fields denoted by an asterisk ().

Alert type
Verastem Inc End-of-Day Stock Quote Alert
Verastem Inc SEC Alert
Verastem Inc Calendar Alert
Verastem Inc News Alert

January 29, 2020	Verastem Oncology Announces Dosing of First Patient in CSPC’s Chinese Study Evaluating COPIKTRA® (Duvelisib) in Patients with Relapsed or Refractory Follicular Lymphoma
January 8, 2020	Verastem Oncology Announces Global Licensing Agreement with Chugai Pharmaceutical Co., Ltd. to Develop and Commercialize RAF/MEK Inhibitor CH5126766
January 6, 2020	Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Press Releases

E-mail Alerts

Investor Contact

John Doyle

Joe Rayne